Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations

Detlef Bockenhauer1, Sally Feather, Horia C Stanescu

  • 1Great Ormond Street Hospital-University College London, London, United Kingdom.

Insights

Mutations in the KCNJ10 gene cause EAST syndrome, a rare disorder characterized by epilepsy, ataxia, deafness, and kidney tubulopathy. This discovery highlights KCNJ10

Area of Science:

  • Genetics
  • Nephrology
  • Neurology
  • Otolaryngology

Background:

  • Five children from two families presented with a rare autosomal recessive disorder.
  • The syndrome, termed EAST syndrome, is characterized by epilepsy, ataxia, sensorineural deafness, and renal salt-losing tubulopathy.
  • Affected individuals exhibited hypokalemic metabolic alkalosis and normotension.

Purpose of the Study:

  • To investigate the genetic basis of the described autosomal recessive disorder (EAST syndrome).
  • To identify the specific gene responsible for the observed clinical phenotype.

Main Methods:

  • Whole-genome linkage analysis was conducted in affected individuals from one family.
  • Candidate gene KCNJ10 was sequenced, and identified mutations were functionally evaluated using heterologous expression in xenopus oocytes.
  • Protein expression and function were further assessed in genetically modified Kcnj10-deleted mice.

Main Results:

  • Linkage analysis identified a significant locus on chromosome 1q23.2, containing the KCNJ10 gene.
  • Homozygous missense mutations in KCNJ10 were found in affected individuals from both families.
  • Expressed mutations significantly reduced potassium currents; Kcnj10-deleted mice exhibited renal salt wasting and dehydration.

Conclusions:

  • Mutations in the KCNJ10 gene are the cause of EAST syndrome, a disorder encompassing epilepsy, ataxia, sensorineural deafness, and tubulopathy.
  • KCNJ10 plays a critical role in renal salt handling and may be involved in blood pressure regulation.
Abstract

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...